Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)
Clinical trial NCT05743244 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05743244
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-19
- Primary completion
- 2026-06-30
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.